This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Semble Secures £30M Series C
Business Series C funding

Semble Secures £30M Series C

Analysis based on 6 articles · First reported Jun 04, 2026 · Last updated Jun 04, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The successful Series C funding round for Semble indicates strong investor confidence in the healthcare technology sector, particularly in solutions addressing fragmentation and improving patient care. This investment is expected to fuel Semble's expansion, potentially increasing its market share in the UK and France, and driving innovation in AI-powered care orchestration, which could positively impact the broader healthtech market.

Healthcare Technology Venture Capital
Event Summary

Semble, a healthcare technology company, has successfully secured a £30 million Series C funding round. The round was led by Revaia, with new investor Partech joining, and existing investors VSR Ventures Private Limited and Octopus Group continuing their support. This funding will enable Semble to expand its AI-powered care orchestration capabilities, accelerate growth in France, and further penetrate large healthcare groups. Semble's platform is currently used by over 10 million patients and 16,000 healthcare professionals across 1,700 organizations, including notable customers like Nuffield Health and London Doctors Clinic. The investment comes as healthcare providers in the United Kingdom and Europe face increasing operational challenges due to fragmented technology and rising patient demand. Semble aims to address these issues by providing an intelligent orchestration layer for modern healthcare delivery.

Entities Involved
oth
Semble
Semble secured £30 million in Series C funding, which will be used to expand its AI-powered care orchestration capabilities, accelerate growth in France, and expand within large healthcare groups. This funding validates its position as a leading healthcare technology company.
Importance 100.0 Sentiment 80.0
priv
Revaia
Revaia led the Series C funding round for Semble, demonstrating its conviction in the long-term transformation of healthcare and strengthening its portfolio in the healthtech sector.
Importance 90.0 Sentiment 60.0
per
Christoph Lippuner
Christoph Lippuner, CEO and co-founder of Semble, articulated the company's vision for intelligent care orchestration and the strategic use of the new investment to scale across the UK and Europe.
Importance 80.0 Sentiment 70.0
priv
Partech
Partech participated as a new investor in Semble's Series C funding round, expanding its investment in European impact technology B2B champions, particularly in healthcare.
Importance 70.0 Sentiment 50.0
per
Morgan Kessous
Morgan Kessous, Partner at Revaia, expressed strong confidence in Semble's platform and its potential to lead the reshaping of the European healthcare market.
Importance 70.0 Sentiment 60.0
per
Mikael Landau
Mikael Landau is a co-founder of Semble, contributing to the company's success in securing significant Series C funding.
Importance 60.0 Sentiment 60.0
priv
Octopus Group
Octopus Group continued its backing of Semble in the Series C funding round, showing sustained support for the healthcare technology company.
Importance 50.0 Sentiment 40.0
priv
VSR Ventures Private Limited
VSR Ventures Private Limited continued its backing of Semble in the Series C funding round, indicating ongoing confidence in the company's growth and market position.
Importance 50.0 Sentiment 40.0
cnt
United Kingdom
The United Kingdom is a key market for Semble, with over 10 million patients using its platform and the company being widely adopted in private healthcare across the country.
Importance 30.0 Sentiment 0.0
cnt
France
France is a target market for Semble's expansion, where its platform has demonstrated significant regulatory maturity in less than a year.
Importance 30.0 Sentiment 0.0
priv
Nuffield Health
Nuffield Health is a customer of Semble, benefiting from its healthcare management platform.
Importance 20.0 Sentiment 0.0
oth
Welbeck
Welbeck is a customer of Semble, utilizing its platform for care orchestration.
Importance 20.0 Sentiment 0.0
priv
London Doctors Clinic
London Doctors Clinic is a customer of Semble, leveraging its healthcare technology.
Importance 20.0 Sentiment 0.0
oth
Modality
Modality is a customer of Semble, integrating its platform into their healthcare operations.
Importance 20.0 Sentiment 0.0
oth
ProblemShared
ProblemShared is a customer of Semble, benefiting from its comprehensive healthcare management solution.
Importance 20.0 Sentiment 0.0
Relationships
VSR Ventures Private Limited related ↔ United Kingdom
VSR Ventures Private Limited related ↔ France
United Kingdom allies ↔ France The United Kingdom relies on its alliance with France for regional security, joint naval operations, and nuclear defense
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.